Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Whole exome DNA sequence analysis of Brca2 and Trp53 deficient mouse mammary gland tumours

Francis, Jeffrey C., Melchor, Lorenzo, Campbell, James, Kendrick, Howard, Wei, Wenbin, Armisen-Garrido, Javier, Assiotis, Ioannis, Chen, Lina, Kozarewa, Iwanka, Fenwick, Kerry, Swain, Amanda, Smalley, Matthew John ORCID:, Lord, Christopher J. and Ashworth, Alan 2015. Whole exome DNA sequence analysis of Brca2 and Trp53 deficient mouse mammary gland tumours. Journal of Pathology 236 (2) , pp. 186-200. 10.1002/path.4517

[thumbnail of 14-611 1 Francis et al revised.pdf]
PDF - Accepted Post-Print Version
Download (1MB) | Preview


Germline mutations in the tumour suppressor BRCA2 predispose to breast, ovarian and a number of other human cancers. Brca2-deficient mouse models are used for preclinical studies but the pattern of genomic alterations in these tumours has not yet been described in detail. We have performed whole-exome DNA sequencing analysis of mouse mammary tumours from Blg–Cre Brca2f/f Trp53f/f animals, a model of BRCA2-deficient human cancer. We also used the sequencing data to estimate DNA copy number alterations in these tumours and identified a recurrent copy number gain in Met, which has been found amplified in other mouse mammary cancer models. Through a comparative genomic analysis, we identified several mouse Blg–Cre Brca2f/f Trp53f/f mammary tumour somatic mutations in genes that are also mutated in human cancer, but few of these genes have been found frequently mutated in human breast cancer. A more detailed analysis of these somatic mutations revealed a set of genes that are mutated in human BRCA2 mutant breast and ovarian tumours and that are also mutated in mouse Brca2-null, Trp53-null mammary tumours. Finally, a DNA deletion surrounded by microhomology signature found in human BRCA1/2-deficient cancers was not common in the genome of these mouse tumours. Although a useful model, there are some differences in the genomic landscape of tumours arising in Blg–Cre Brca2f/f Trp53f/f mice compared to human BRCA-mutated breast cancers. Therefore, this needs to be taken into account in the use of this model.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Biosciences
European Cancer Stem Cell Research Institute (ECSCRI)
Subjects: R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Uncontrolled Keywords: Brca2; mammary gland; mouse model; exome sequencing
Publisher: Wiley
ISSN: 0022-3417
Date of First Compliant Deposit: 30 March 2016
Date of Acceptance: 11 February 2015
Last Modified: 11 Nov 2023 03:18

Citation Data

Cited 11 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item


Downloads per month over past year

View more statistics